Cargando…
33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
BACKGROUND: A single intranasal (IN) dose of 10(8) TCID(50) M2SR protected a responder subset of adults against infection and disease in a prior human influenza challenge study (EudraCT number: 2017-004971-30). Higher dose levels of M2SR were assessed in this phase 1b study to enhance immune respons...
Autores principales: | Eiden, Joseph, Ellis, Ruth, Fierro, Carlos, Schwartz, Howard, Adams, Mark, Ellis, Kimberly, Aitchison, Roger, Herber, Renee, Bilsel, Pamuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776045/ http://dx.doi.org/10.1093/ofid/ofaa439.078 |
Ejemplares similares
-
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022) -
2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain
por: Eiden, Joseph, et al.
Publicado: (2019) -
1155. Coadministration of Intranasal M2SR (M2-deficient Single Replication) Investigational Influenza Vaccine with Fluzone High Dose Induces Superior Immune Responses to Fluzone High Dose Alone in 65-85 Year Old Adults
por: Eiden, Joseph, et al.
Publicado: (2023) -
1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults
por: Eiden, Joseph, et al.
Publicado: (2018) -
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults
por: Eiden, Joseph, et al.
Publicado: (2021)